Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Calvo

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2010
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patientsDelphine Kérob, Raphael Porcher, Olivier Vérola, et al.
Nature Genetics|May 8, 2012
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaCécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, et al.
Biomedicine Hub|August 11, 2020
Propelling Health Care into the TwentiesDenis Horgan, Bettina Borisch, Etienne Richer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2016
Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAVJean-Charles Nault, Iadh Mami, Tiziana La Bella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Improving cancer outcomes through international collaboration in academic cancer treatment trialsEdward L Trimble, Jeffrey S Abrams, Ralph M Meyer, et al.
Cancer Cell|April 17, 2014
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformationCamilla Pilati, Eric Letouzé, Jean-Charles Nault, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
Nature Medicine|July 8, 2020
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board PortalDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
Nature Genetics|December 2, 2008
Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafnessChantal Lagresle-Peyrou, Emmanuelle M Six, Capucine Picard, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2010
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patientsDelphine Kérob, Raphael Porcher, Olivier Vérola, et al.
Nature Genetics|May 8, 2012
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaCécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, et al.
Biomedicine Hub|August 11, 2020
Propelling Health Care into the TwentiesDenis Horgan, Bettina Borisch, Etienne Richer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2016
Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAVJean-Charles Nault, Iadh Mami, Tiziana La Bella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Improving cancer outcomes through international collaboration in academic cancer treatment trialsEdward L Trimble, Jeffrey S Abrams, Ralph M Meyer, et al.
Cancer Cell|April 17, 2014
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformationCamilla Pilati, Eric Letouzé, Jean-Charles Nault, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
Nature Medicine|July 8, 2020
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board PortalDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
Nature Genetics|December 2, 2008
Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafnessChantal Lagresle-Peyrou, Emmanuelle M Six, Capucine Picard, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Pageof 9